Semaglutide Approved for Type 2 Diabetes

The FDA has approved semaglutide (marketed as Ozempic) to improve glycemic control in adults with type 2 diabetes, the manufacturer announced. The glucagon-like peptide...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news